GlassScriptPhysician profile
Stephanie K Repole
NPI 1164683009
$1,905.72
in general payments reported to CMS, 2019-2025
15 companies · $177 in 2025
The $177 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $508 · 2020: $153 · 2021: $23.63 · 2022: $249 · 2023: $505 · 2024: $291 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $972.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $971.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $593.06 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Molli Surgical (US) INC | $587.74 | 2023-2024 | |
| Musculoskeletal Transplant Foundation INC. | $198.82 | 2022 | |
| Allergan, INC. | $107.40 | 2019 | |
| Stryker Corporation | $97.46 | 2023 | Pinpoint |
| Merck Sharp & Dohme LLC | $77.62 | 2023-2025 | Keytruda, Lynparza |
| Baxter Healthcare | $66.64 | 2019 | |
| Novo Nordisk INC | $39.97 | 2020-2022 | |
| Cardinal Health 414 LLC | $28.45 | 2024 | Kit For The Preparation of Lymphoseek (Technetium Tc 99m Tilmanocept) |
| Acell, INC. | $25.70 | 2019 | |
| Genentech USA, INC. | $21.27 | 2019 | |
| Myriad Genetic Laboratories, INC. | $18.39 | 2022 | |
| Becton, Dickinson and Company | $15.72 | 2019 | |
| Sanara Medtech INC. | $13.83 | 2025 | Celleraterx |
| Bioptics, INC. | $13.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Repole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.